Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome.

PloS one - 1 Jan 2015

Shamai Sivan, Nabiochtchikov Ilana, Kraus Sarah, Zigdon Sally, Kazanov Dina, Itzhak-Klutch Michal, Eizner Carmit, Arber Nadir, Geva Ravit

Abstract excerpt

BACKGROUND: There are no validated biomarkers that correlate with the prognosis of pancreatic ductal adenocarcinoma (PDA). The CD24 and adenomatous polyposis coli (APC) genes are important in the malignant transformation of gastrointestinal cells. This study examined APC and CD24 genetic polymorphisms and their possible impact on survival of patients with PDA. METHODS: Clinical and pathological data as well as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenomatous Polyposis Coli Protein
Share to Carcinoma, Pancreatic Ductal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD24 Antigen

Share to DNA, Neoplasm

Share to Kaplan-Meier Estimate

Share to Neoplasm Metastasis

Share to Pancreatic Neoplasms

Share to Real-Time Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 26394139
DOI: 10.1371/journal.pone.0134469
PMCID: PMC4579075

Genes

APC

Variants

rs52812045
rs52812045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome.PMID 26394139Read ↗

TP53 c.730G > A pathogenic variant as a plausible candidate biomarker in pancreatic ductal adenocarcinoma patients from Karachi, pakistan: a retrospective cohort study.Semantic proximity Read ↗

Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma.Semantic proximity Read ↗

CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma.Semantic proximity Read ↗

dCK Expression and Gene Polymorphism With Gemcitabine Chemosensitivity in Patients With Pancreatic Ductal Adenocarcinoma: A Strobe-Compliant Observational Study.Semantic proximity Read ↗

TP53 Arg72Pro Polymorphism and Pancreatic Cancer Susceptibility: Assessing rs1042522 as a Risk Factor for Pancreatic CancerSemantic proximity Read ↗

Prospective validation of a predictive non-invasive SNP-based biomarker signature in resectable pancreatic cancer: a study protocolSemantic proximity Read ↗

CD86 gene variants and susceptibility to pancreatic cancer.Semantic proximity Read ↗

Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancers.Semantic proximity Read ↗

Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians.Semantic proximity Read ↗

Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel.Semantic proximity Read ↗

Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients.Semantic proximity Read ↗

MDM2 promoter polymorphism and pancreatic cancer risk and prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.